Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.

Cancer genetics - 1 Oct 2011

Bie Li, Zhao Gang, Ju Yan, Zhang Bo

Abstract excerpt

Meningiomas are a common type of primary central nervous system tumor. Patients with atypical meningioma are difficult to treat and their disease often recurs. The aim of this study was to examine the role of CCNB1 and CDC2 as factors in recurrent meningiomas. A total of 37 sporadic meningioma samples were collected after surgery. The messenger RNA (mRNA) levels of the biomarkers CCNB1, CDC2, and MKI67 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CDC2 Protein Kinase
Share to Cyclin B
Share to Cyclin B1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinases

Share to Genes, cdc

Share to Meningeal Neoplasms

Share to Meningioma

Share to Microarray Analysis

Source

Identifiers

PMID: 22137483
DOI: 10.1016/j.cancergen.2011.08.019

Genes

CCNB1
MKI67

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.PMID 22137483Read ↗

Genetic Alterations Associated With Progression and Recurrence in MeningiomasSemantic proximity Read ↗

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free SurvivalSemantic proximity Read ↗

Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomasSemantic proximity Read ↗

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumorsSemantic proximity Read ↗

Multiomic and clinical analysis of multiply recurrent meningiomas reveals risk factors, underlying biology, and insights into evolutionSemantic proximity Read ↗

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumorsSemantic proximity Read ↗

Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumorsSemantic proximity Read ↗

Genomic landscape of meningiomas.Semantic proximity Read ↗

Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomasSemantic proximity Read ↗

Microarray gene expression profiling in meningiomas: Differential expression according to grade or histopathological subtypeSemantic proximity Read ↗

ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.Semantic proximity Read ↗

A microRNA expression signature predicts meningioma recurrenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.